🇺🇸 FDA
Pipeline program

High-dose anrikefon

2025R0444

Approved small_molecule active

Quick answer

High-dose anrikefon for Laparoscopic Surgery is a Approved program (small_molecule) at First Tracks Biotherapeutics with 2 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Laparoscopic Surgery
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials